Showing 1 - 10 of 34
It is acknowledged that economic evaluation methods as they have been developed for Health Technology Assessment do not capture all the costs and benefits relevant to the assessment of public health interventions. This paper reviews methods that could be employed to measure and value the broader...
Persistent link: https://www.econbiz.de/10009753411
Persistent link: https://www.econbiz.de/10009551794
Persistent link: https://www.econbiz.de/10009551796
Persistent link: https://www.econbiz.de/10009551798
Persistent link: https://www.econbiz.de/10009551808
Persistent link: https://www.econbiz.de/10009552428
Background: The amount of out-of-pocket (OOP) payments within the German health care system has risen steadily within the last years. OOP payments aim to strengthen patients' cost awareness and try to restrict the demand on medical necessary treatments. However, besides the intended decline of...
Persistent link: https://www.econbiz.de/10010526631
The next generation of artificial vision devices (AVDs), which is currently developed in pre-clinical settings, has the potential to improve the vision of blind patients with retinitis pigmentosa (RP) in a manner that they will be categorized as visual impaired but no more as blind. This...
Persistent link: https://www.econbiz.de/10010526936
South-East Asian Regional (SEAR) countries range from low- to middle-income countries and have considerable differences in mix of public and private sector expenditure on health. This study intends to estimate the income-elasticities of healthcare expenditure in public and private sectors...
Persistent link: https://www.econbiz.de/10010530062
Background: Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the use of DAM is optional within HTAs of the German Institute of Medical...
Persistent link: https://www.econbiz.de/10010530072